Can I use penicillin (e.g., penicillin V) to treat my infection when infectious mononucleosis cannot be ruled out?

Avoid Penicillins When Infectious Mononucleosis Cannot Be Ruled Out

You should NOT use penicillin V (or any penicillin/aminopenicillin) to treat your infection when infectious mononucleosis (IM) cannot be ruled out—wait for diagnostic confirmation or choose an alternative antibiotic class entirely. 1, 2

Why This Matters: The Rash Problem

When penicillins (especially ampicillin/amoxicillin, but also penicillin V and benzylpenicillin) are given during acute IM, up to 90% of patients develop a generalized maculopapular rash 1. This is not a typical allergic reaction—it's a unique interaction between the EBV infection and the penicillin molecule itself:

• The rash is typically erythematous, highly pruritic, and can become generalized 2
• It appears even in patients with no prior penicillin allergy history 1
• The mechanism involves altered drug sensitivity during acute IM, not true IgE-mediated allergy 1, 3

The Long-Term Consequence You Need to Know

Recent evidence shows this isn't just a temporary nuisance—nearly half of adolescents and adults who develop EBV-related rashes after penicillin treatment show evidence of persistent drug allergy years later 4. This means:

• Positive skin tests persist long after IM resolves
• Patients can experience recurrent delayed hypersensitivity reactions upon re-exposure
• You may unnecessarily restrict antibiotic options for life 4

The Clinical Algorithm

When IM Cannot Be Ruled Out:

1. Do NOT prescribe penicillins (including penicillin V, amoxicillin, ampicillin, or amoxicillin-clavulanate) 1, 2

2. If bacterial pharyngitis needs treatment (e.g., suspected Group A Strep):

   • Choose a non-penicillin alternative (e.g., cephalosporins if no severe penicillin allergy, or macrolides)
   • The evidence specifically states: "an appropriate antibiotic other than ampicillin-amoxycillin can be chosen" 2

3. Confirm or exclude IM first using:

   • Complete blood count (>40% lymphocytes, >10% atypical lymphocytes) 5
   • Rapid heterophile antibody test (87% sensitivity, 91% specificity) 5
   • If negative but clinical suspicion high: check liver enzymes and consider EBV viral capsid antigen testing 5

The Evidence on Skin Testing

Interestingly, skin testing with penicillins during acute IM shows reactivity in 84% of patients (16/19), with two-thirds reacting to ampicillin and half to benzylpenicillin 3. Cloxacillin showed no reactions, suggesting the issue is specific to certain penicillin structures 3. This reactivity disappears after the acute stage resolves 3, but the newer data 4 shows persistence in many cases.

Common Pitfall to Avoid

The real-world problem: IM mimics streptococcal pharyngitis so closely that 82.6% of hospitalized IM patients had already received antibiotics before diagnosis 6, with amoxicillin-clavulanate being the most common choice (46.2%) 6. The FDA label for penicillin V emphasizes it should only be used for "proven or strongly suspected bacterial infection" 7, yet the clinical overlap makes this distinction difficult 8.

Bottom Line for Practice

There is no indication for antibiotics in IM unless throat cultures reveal bacterial pathogens 2. When bacterial co-infection requires treatment and IM cannot be excluded, select a non-penicillin antibiotic. The risk of creating a lifelong drug allergy 4 far outweighs any theoretical benefit of empiric penicillin therapy in this setting.